Virtus ETF Advisers LLC Akebia Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.67 $20,847 - $43,649	-65,149 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.72 - $2.93 $2,783 - $11,327	-3,866 Reduced 5.6%	65,149 $47,000
Q4 2021 Feb 14, 2022	BUY	$2.26 - $3.34 $24,344 - $35,978	10,772 Added 18.49%	69,015 $156,000
Q3 2021 Nov 15, 2021	SELL	$2.35 - $3.88 $7,146 - $11,799	-3,041 Reduced 4.96%	58,243 $168,000
Q2 2021 Aug 10, 2021	SELL	$2.83 - $4.2 $93,808 - $139,221	-33,148 Reduced 35.1%	61,284 $232,000
Q1 2021 May 17, 2021	BUY	$2.92 - $5.06 $4,850 - $8,404	1,661 Added 1.79%	94,432 $320,000
Q4 2020 Feb 12, 2021	BUY	$2.22 - $3.78 $144,799 - $246,550	65,225 Added 236.79%	92,771 $260,000
Q3 2020 Nov 13, 2020	SELL	$2.39 - $13.08 $8,955 - $49,010	-3,747 Reduced 11.97%	27,546 $69,000
Q2 2020 Aug 05, 2020	SELL	$6.67 - $13.58 $166,596 - $339,187	-24,977 Reduced 44.39%	31,293 $425,000
Q1 2020 May 14, 2020	SELL	$4.1 - $10.24 $33,644 - $84,029	-8,206 Reduced 12.73%	56,270 $427,000
Q4 2019 Feb 13, 2020	BUY	$3.16 - $6.73 $8,993 - $19,153	2,846 Added 4.62%	64,476 $407,000
Q3 2019 Nov 12, 2019	SELL	$3.55 - $5.4 $12,187 - $18,538	-3,433 Reduced 5.28%	61,630 $242,000
Q2 2019 Aug 13, 2019	BUY	$4.1 - $8.05 $129,350 - $253,969	31,549 Added 94.14%	65,063 $315,000
Q1 2019 May 14, 2019	SELL	$5.41 - $8.73 $25,259 - $40,760	-4,669 Reduced 12.23%	33,514 $274,000
Q4 2018 Feb 05, 2019	SELL	$5.39 - $9.15 $20,773 - $35,264	-3,854 Reduced 9.17%	38,183 $211,000
Q3 2018 Nov 14, 2018	SELL	$7.44 - $10.65 $225,960 - $323,451	-30,371 Reduced 41.94%	42,037 $371,000
Q2 2018 Aug 10, 2018	BUY	$9.15 - $11.34 $200,805 - $248,867	21,946 Added 43.49%	72,408 $723,000
Q1 2018 May 14, 2018	BUY	$9.53 - $15.68 $257,338 - $423,407	27,003 Added 115.11%	50,462 $481,000
Q4 2017 Feb 14, 2018	BUY	$14.24 - $19.59 $6,265 - $8,619	440 Added 1.91%	23,459 $349,000
Q3 2017 Nov 14, 2017	BUY	$13.06 - $19.67 $27,504 - $41,425	2,106 Added 10.07%	23,019 $453,000
Q2 2017 Aug 14, 2017	BUY	N/A	20,913	20,913 $301,000

Others Institutions Holding AKBA

# of Institutions

120

Shares Held

54.9M

Call Options Held

291K

Put Options Held

179K

Black Rock Inc. New York, NY

11.6M
Shares

$27.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$23.5 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$13.4 Million
13.23% of portfolio
Geode Capital Management, LLC Boston, MA

4.75M
Shares

$11.1 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.72M
Shares

$8.66 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $428M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account